NorthWest Biotherapeutics Inc (NWBO)

[GD]

NWBO longs should learn from AMRN experiences, science is the most
important factor of success or failure of PIII trials, very low stock
price are easy to manipulate, in NWBO case, $1 or $2 million can drive
NWBO to what ever target they want, DNDN's drug provenge has shown NWBO's
drug proof of concept and works, just like Japan's JELIS proved EPA
works on reducing CV events but street chose to not believe. Beware
NWBO is battle ground stock, so risk is high and reward is in term of
X times, in NWBO's case, failure, 75% loss from 20 cent to 5 cents and
reward is 5 to 25 times in days depending how strong is the HR, IMO.
Remember, OS HR is the gold standard endpoint for cancer PIII trials!!!!
FDA and street can not argue a cancer patient is live or dead!!!